Viewing Study NCT04516551


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-19 @ 12:17 AM
Study NCT ID: NCT04516551
Status: UNKNOWN
Last Update Posted: 2020-11-17
First Post: 2020-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT
Sponsor: Xinqiao Hospital of Chongqing
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: Anti-CD19 allo-CAR-T
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None INDUSTRY View